Parallel Advisors, LLC Amneal Pharmaceuticals, Inc. Transaction History
Parallel Advisors, LLC
- $4.18 Billion
- Q3 2024
A detailed history of Parallel Advisors, LLC transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Parallel Advisors, LLC holds 31 shares of AMRX stock, worth $247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31
Previous 31
-0.0%
Holding current value
$247
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AMRX
# of Institutions
183Shares Held
141MCall Options Held
57KPut Options Held
49K-
Ubs Group Ag21.8MShares$174 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.6MShares$117 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$98.3 Million2.45% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$89.9 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$85.5 Million2.48% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.21B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...